Navigation Links
NUCRYST Pharmaceuticals appoints a new director
Date:1/16/2009

PRINCETON, NJ, Jan. 16 /PRNewswire-FirstCall/ - Thomas E. Gardner, Chairman, announced today that G. A. (Drew) Fitch has been appointed to the NUCRYST Pharmaceuticals' Board of Directors.

Mr. Fitch is the President and Chief Executive Officer of The Westaim Corporation ("Westaim"), NUCRYST's controlling shareholder, holding approximately 75% of NUCRYST's outstanding common shares. Prior to his appointment as President and Chief Executive Officer of Westaim in 2007, Mr. Fitch had been Senior Vice President and Chief Financial Officer of Westaim since 1997. Before joining Westaim, Mr. Fitch was Senior Vice President and Chief Financial Officer of Western Star Trucks Holdings Ltd., a manufacturer of city transit buses and highway trucks, and Senior Vice President, Finance & CFO of Canadian Airlines Corporation, an international airline company.

"The addition of Drew Fitch to the NUCRYST Board of Directors adds a seasoned director and will help us to coordinate our priorities with Westaim," said Tom Gardner. "On behalf of the Board, we extend to Drew a warm welcome", added Gardner.

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith & Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by pain, infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101 for use in medical devices and as an act
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
2. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
3. NUCRYST Receives Deficiency Notice from NASDAQ
4. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
5. NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
6. NUCRYST Announces First Quarter 2008 Financial Results
7. NUCRYST Announces Management Realignment and R&D Portfolio Change
8. NUCRYST Announces Senior Management Change
9. NUCRYST Pharmaceuticals announces year-end results
10. NUCRYST Pharmaceuticals announces 2007 third quarter results
11. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ric Effort but Points out Potential Risk if Americ...are Reform ,, NEW YORK, Dec. 4 /PRNewswire-US... today published a Perspective opinion piece add...edlener, M.D., president, Children,s Health Fund a...ness and Professor of Clinical Population & Fa...
(Date:12/4/2009)... winter isn,t known, CDC says, , , FRID...s reporting widespread swine flu activity continue...just two weeks ago, a U.S. health official said Fr... vaccine continues to increase, Dr. Thomas R. Frie...rol and Prevention, said during an afternoon press...
(Date:12/4/2009)...research shows , , FRIDAY, Dec. 4 (Healt...ttes for smoking tobacco, researchers say. , A ... a water pipe inhale carbon monoxide and nicotine,...otine addiction. , The study included 31 volunt...ter pipe and a single cigarette. After each smokin...
(Date:12/4/2009)...growth after heart attack , , FRIDAY, De...o help repair heart attack damage, a new study sho...at stem cells from donor bone marrow promoted the ...d by heart attack. , The patients received the ...art attack. During follow-up, they were compared t...
(Date:12/4/2009)...ire-FirstCall/ -- When the spread of H1N1 flu acce...lth Services needed to get more information to mor...c Foundry, Inc. (Nasdaq: SOFO ), the recognized ...dge management, for a live webinar in which Matt D...ces, will share how in-house webcasting relieved f...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Swine Flu Continues to Wane 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
..., plain and simple, a machine shaped by genetics a...ofessor of biomedical engineering at Washington Un..., stresses and deformations of the heart since the...as developed a theory on tissue growth and morphog...
...cks more quickly and with greater accuracy if they... At the moment, the blood test is usually the fou...earlier on, the researchers argue, it would also s...on, the journal of the American Cardiac Associatio...
...ning technique for persons suffering from types of...und says investigations of skin lesions may allow ... group of cancers, particularly those of the colon...s colorectal cancer syndrome - it may be possible ...
...he evil effects of chicken pox virus.Yes !! these ... of brain tumors later in life. In the previo... unexpected finding was that the patients with bra... the fact that glioma patients are also less like...
...l Human Genome Project (HGP) have identified chrom...centration of disease genes.Out of 23 pairs of hum...th genetic disease. Over the next 20 years t...nging from asthma to Alzheimer's disease as well a...
...m about? Their own rat races! Read on to know more...sts at the Massachusetts Institute of Technology, ... races and that they might in the long run help sc...ing and kicking in their dreams. But not everyone ...
Other Medicine News:Health News:Mechanical forces drive early heart development 2Health News:Blood test for diagnosis of heart attacks 2
(Date:12/4/2009)... Axsun Technologies, Inc.... (Nasdaq: VOLC ), today announced the initial dev...ted light source architecture for OCT imaging. Ax...n raises the bar on imaging speed and overcomes fu...wept source OCT light sources. This approach to o...
(Date:12/4/2009)...ire-FirstCall/ -- Northwest Biotherapeutics, Inc. ...O) announced today that the US Patent and Trademar...ystem for automation of the initial stages of the ...ic cancer vaccines. These initial manufacturing s...ndritic cells (which are the critical ingredient) ...
(Date:12/3/2009)...TE COLLEGE, Pa., Dec. 3 Ambry Gene...of an agreement to provide extended bioinformatics...ftware for next-generation sequencing projects per...om.com/cgi-bin/prnh/20090428/LA06744LOGO ) ,, A...t Ambry has been providing genomics solutions on I...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Palatin Technologies Inc Reports Positive Bremelanotide Study 3B Improved Safety Profile with Subcutaneous Administration 13520 1Palatin Technologies Inc Reports Positive Bremelanotide Study 3B Improved Safety Profile with Subcutaneous Administration 13520 2Palatin Technologies Inc Reports Positive Bremelanotide Study 3B Improved Safety Profile with Subcutaneous Administration 13520 3Palatin Technologies Inc Reports Positive Bremelanotide Study 3B Improved Safety Profile with Subcutaneous Administration 13520 4Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device 54292 1Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device 54292 2The Wonder 28R 29 You Love Now Offers Even More of the Nutrition You Need Wonder Classic and Wonder Classic Sandwich Provide Even More Calcium and N 54290 1The Wonder 28R 29 You Love Now Offers Even More of the Nutrition You Need Wonder Classic and Wonder Classic Sandwich Provide Even More Calcium and N 54290 2
...aq: BNVI ) announced the company will present re...ad drug candidate for advanced metastatic breast,c...logy,s Fifth International,Conference in Atlanta, ...cted,as a top scoring abstract and will be present...ember 20, 2008. , The Phase 1B clinical tria...
...ive,registry presented this week at the 35th Annua...llis(R) Peripheral Infusion System from Bacchus,Va... up the blood clot in most,patients in about 20 mi...rmacomechanical thrombolysis, restores,blood flow ...cted thrombolysis,(CDT) techniques. It provides a...
Other Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3
Triad Plus Povidone Iodine (PVP-I) Sponge Sticks
ChloraPrep® 26 mL (Scrub Teal™)
...e Anti-HCV Low Titer Performance Panel consists of...k to strong positive for antibodies to the Hepatit...anufacturers and diagnostic laboratories to evalua...all major test systems are included for comparativ...
Pelvitex™ Polypropylene Mesh
Medicine Products: